TGTX

SEC filing TGTX Reports Positive Topline Results from ENHANCE Trial, Meets Primary Endpoint for BRIUMVI Single Infusion Regimen, Targets sBLA Filing in 2H-2026

5d ago

News TG Therapeutics posts late-stage trial win for Briumvi single infusion regimen

6d ago

News TG Therapeutics Q2 Revenue Up 91%

14d ago

News Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?

14d ago

SEC filing TGTX Reports $205M Q1 Revenue, $195M BRIUMVI Sales, Raises 2026 Guidance to $925M

27d ago

SEC filing TGTX Secures $750M Term Loan, $250M Add-On Facility, 2031 Maturity, SOFR+100bps+Pricing Grid

73d ago

News TG Therapeutics secures $750M credit facility with Blue Owl, boosts buyback to $300M

75d ago

News Top Quant rated bullish mid cap stocks among companies with high short interest

111d ago

Scanner Unusual volume (1.8x average)

118d ago

News 2 Portfolio Worthy Value Stocks to Consider After Q4 Results

123d ago

News Compass Point Maintains Buy Rating on Invesco Mortgage (IVR), Citing Wider-Than-Average Mortgage Spreads

123d ago

News Invesco’s Yang on Potential Fed Chair Nominee

123d ago

News $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)

132d ago

News Shareholder Alert: The Ademi Firm investigates whether RAPT Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

132d ago

News Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)

139d ago

News Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO® (copper histidinate)

140d ago